| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8780370 | Gynecologic Oncology | 2018 | 8 Pages |
Abstract
HOXA4/HOXB3 gene expression-based risk score may be useful for prognostic risk stratification and warrants prospective validation in HGSOC patients.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Katherine R. Miller, Jai N. Patel, Qing Zhang, Eric J. Norris, James Symanowski, Chad Michener, Jalid Sehouli, Ioana Braicu, Darla D. Destephanis, Ashley P. Sutker, Wendell Jones, Chad A. Livasy, Charles Biscotti, Ram N. Ganapathi, David L. Tait,